Once considered low risk, this group is now facing a health crisis. The leading researcher studying AAPI cancer rates tells ...

I, a protein platform for reprogramming immune responses. A better understanding of its structure may help optimize designs for the platform, which can be used to develop cancer treatments by either ...

For example, it can help with managing certain side effects of treatment, such as fatigue. But research shows exercise can ...

Some early breast cancer patients can safely avoid certain surgeries. That's according to two studies published Thursday that ...

Research by Cancer Center genetic epidemiologist Burcu Darst, PhD, and scientists from the Canary Prostate Active ...

Tampa General Hospital (TGH) today announced the opening of a new outpatient Cellular-Immunotherapy Transplant Unit (CTU) at ...

Researchers have successfully developed a deep learning model that classifies pancreatic ductal adenocarcinoma (PDAC), the most common form of ...

Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced the results of a large-scale study which shows that its Nu.Q® Cancer Test differentiated ...

Learn about stomach cancer symptoms, causes, and treatments. Understand risk factors and prevention to reduce your chances of ...

Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion” or the "Company”), a clinical-stage biotech developing RNA ...

Analysis - A breakthrough study has identified the genetic risk factors that contribute to increased prostate cancer in ...